Keele Research Repository
Explore the Repository
Article
Pervan, M, Marijan, S, Markotić, A, Pilkington, LI, Haverkate, NA, Barker, D, Reynisson, J
ORCID: https://orcid.org/0000-0003-4174-9512, Meić, L, Radan, M and Čikeš Čulić, V
(2022)
Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism.
International Journal of Molecular Sciences, 23 (19).
Marijan, S, Mastelić, A, Markotić, A, Režić-Mužinić, N, Vučenović, N, Barker, D, Pilkington, LI, Reynisson, J
ORCID: https://orcid.org/0000-0003-4174-9512 and Čulić, VČ
(2021)
Thieno[2,3-b]Pyridine Derivative Targets Epithelial, Mesenchymal and Hybrid CD15s+ Breast Cancer Cells.
Medicines, 8 (7).
Marijan, S, Markotić, A, Mastelić, A, Režić-Mužinić, N, Pilkington, LI, Reynisson, J
ORCID: https://orcid.org/0000-0003-4174-9512 and Čulić, VČ
(2020)
Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment.
Scientific Reports, 10 (1).
11876 - ?.

Up a level
